Cipla posts consolidated PAT of Rs. 362.07 crore in Q4 FY2022
Cipla has reported consolidated financial results for the period ended March 31, 2022
Cipla has reported consolidated financial results for the period ended March 31, 2022
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
The report has estimated 4.74 million deaths for India in 2020 and 2021,
Revolution Aspire CT System is manufactured at the company’s new plant launched under the government’s Production Linked Incentives (PLI) Scheme
Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate
Healthium Medtech, a company focused on products used in surgical, post-surgical and chronic care has ramped up its play in the global healthcare industry. In an interview with Thomas C. Thottathil, Editor, Indian Pharma Post, Anish Bafna, CEO and MD, Healthium Medtech outlines his plans
The minister exhorted the pharmaceutical sector to prepare a plan for the next 25 years
Parkinson’s is not limited to old people, even youngsters can suffer from this disease
This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls
The app serves as a single, integrated, personalized customer platform for da Vinci surgeons
Subscribe To Our Newsletter & Stay Updated